Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...

New research calls into question the high-profile conclusion of the first major study to show a physician's race influences ...

For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...

Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Mark Cuban is a man on a mission — to disrupt the pharmaceutical industry.

Health policy scholar Paul Ginsburg joins the "First Opinion Podcast" to discus Medicare policy and the election.

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Congress is facing a slew of expiring Medicare policies, and the end of Trump's tax cuts and Biden's extra ACA subsidies.

Novo Nordisk asked the FDA to bar compounding pharmacies from making semaglutide, arguing it is too complex for the ...

Linda Barbour thought she was more interested in the Change Healthcare cyberattack than most. Having worked as a medical ...

The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...

Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...